Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin

Home  /  National Uptake and Case Studies  /  Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin
CountryAgencyYear work was carried outLinkDetails of use
AustriaLBI-HTA2018https://hta.lbg.ac.at/page/kontinuierliches-flash-glukosemonitoring-bei-diabetes/de
Inform policy via the HTA newsletter.
CroatiaAAZ2018http://www.hzzo.hr/zdravstveni-sustav-rh/medicinski-proizvodi/National adaptation, added local information. National report with original report used for appraisal process (and decision) related to reimbursement of these technologies.
DenmarkDEFACTUMOngoingNot yet available.
ItalyUCSC2018National adaptation. Added local information.
NorwayNIPHNO2018National adaptation. Made no changes to the EUnetHTA report.
SpainAETSAOngoingThe Spanish HTA body SESCS (Servicio de Evaluación del Servicio Canario de Salud) conducted a report regarding this topic at a national level a couple of years ago. The EUnetHTA report will be disseminated as an updated report to regional decision-makers.
SwitzerlandFOPH SNHTA - Swiss Network for Health Technology AssessmentOngoinghttps://www.bag.admin.ch/dam/bag/de/dokumente/kuv-leistungen/Mittel-%20und%20Gegenst%C3%A4ndeliste/migel-1-7-2018.pdf.download.pdf/Mittel-%20und%20Gegenst%C3%A4ndeliste%20vom%2001.07.2018%20.pdf National adaptation. Added local information.
UK (Scotland)SHTGhttp://www.healthcareimprovementscotland.org/our_work/technologies_and_medicines/shtg_advice_statements/advice_statement_009-18.aspx National adaptation. Made minor changes to information and added local information.